Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney

Pediatric Research

Volumn 57, Issue 1, 2005, Pages 115-123

  Byung, Min Choi ^a   Kee, Hwan Yoo ^a,b   In, Sun Bae ^a   Oh, Mee Hye ^a   Young, Sook Hong ^a   Joo, Won Lee ^a   Soon, Kyum Kim ^a  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; JANUS KINASE; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM CHLORIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CORTEX; KIDNEY PARENCHYMA; KIDNEY TUBULE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING; TRANSCRIPTION INITIATION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA PRIMERS; DNA, COMPLEMENTARY; ENALAPRIL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KIDNEY; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 11144330113     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000148064.27632.1D     Document Type: Article

References (43)

1. Gomez RA, Norwood VF 1995 Developmental consequences of the renin-angiotensin system. Am J Kidney Dis 26:409-431
2. Guron G, Friberg P 2000 An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18:123-137
3. Niimura F, Okubo S, Fogo A, Ichikawa I 1997 Temporal and spatial expression pattern of the angiotensinogen gene in mice and rats. Am J Physiol 272:R142-R147
4. Alcorn D, McCausland JE, Marie C 1996 Angiotensin receptors and development: the kidney. Clin Exp Pharmacol Physiol Suppl 3:S88-S92
5. Yoo KH, Wolstenholme JT, Chevalier RL 1997 Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. Pediatr Res 42:588-592
6. Choi JH, Yoo KH, Cheon HW, Kim KB, Hong YS, Lee JW, Kim SK, Kim CH 2002 Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. Pediatr Res 52:325-332
7. Yoo KH, Cheon HW, Choi BM, Hong YS, Lee JW, Kim SK 1998 Angiotensin converting enzyme inhibition increases apoptosis and BCL-2 expression in the neonatal rat kidney. [abstract] J Am Soc Nephrol 9:512A
8. Yoo KH, Cheon H, Choi BM, Hong YS, Lee JW, Kim SK 1999 Effects of angiotensin converting enzyme inhibition into apoptosis and related genes in the neonatal rat kidney. J Korean Pediatr Soc 42:1086-1095
9. Kang NS, Yim HE, Bae IS, Choi JH, Choi BM, Yoo KH, Hong YS, Lee JW, Kim SK 2003 ACE inhibition modulates transforming growth factor-β receptors in the young rat. Pediatr Nephrol 18:865-871
10. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW 1997 Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29:366-373
11. Huwiler A, van Rossum G, Wartmann M, Pfeilschifter J 1998 Angiotensin II stimulation of the stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin AT1 receptor subtype. Eur J Pharmacol 343:297-302
12. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
13. Bonventre JV, Force T 1998 Mitogen-activated protein kinases and transcriptional responses in renal injury and repair. Curr Opin Nephrol Hypertens 7:425-433
14. Schaeffer HJ, Weber MJ 1999 Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-2444
15. Bokemeyer D, Sorokin A, Dunn MJ 1996 Multiple intracellular MAP kinase signaling cascades. Kidney Int 49:1187-1198
16. Tian W, Zhang Z, Cohen DM 2000 MAPK signaling and the kidney. Am J Physiol 279:F593-F604
17. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME 1995 Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331
18. Hibi M, Lin A, Smeal T, Minden A, Karin M 1993 Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7:2135-2148
19. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P 1995 ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14:1798-1811
20. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ 1995 Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685
21. Livingstone C, Patel G, Jones N 1995 ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J 14:1785-1797
22. Hazzalin CA, Cano E, Cuenda A, Barratt MJ, Cohen P, Mahadevan LC 1996 p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr Biol 6:1028-1031
23. Waas WF, Lo HH, Dalby KN 2001 The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen-activated protein (MAP) kinase alpha. Implications for signal/response profiles of MAP kinase pathways. J Biol Chem 276:5676-5684
24. Gupta S, Campbell D, Derijard B, Davis RJ 1995 Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393
25. Gomez RA, Lynch KR, Chevalier RL, Everett AD, Johns DW, Wilfong N, Peach MJ, Carey RM 1988 Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol 254:F900-F906
26. Holthofer H 1988 Cell type-specific glycoconjugates of collecting duct cells during maturation of the rat kidney. Cell Tissue Res 253:305-309
27. Holthofer H, Schulte BA, Spicer SS 1987 Expression of binding sites for Dolichos bifloris agglutinin at the apical aspect of collecting duct cells in rat kidney. Cell Tissue Res 249:481-485
28. Laitinen L, Virtanen I, Saxen L 1987 Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates. J Histochem Cytochem 35:55-65
29. Tisdale EJ 2001 Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway. J Biol Chem 276:2480-2486
30. Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, Hibi M, Nakabeppu Y, Shiba T, Yamamoto KI 1999 JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol Cell Biol 19:7539-7548
31. Maisonpierre PC, Le Beau MM, Espinosa R 3rd, Ip NY, Belluscio L, de la Monte SM, Squintos Furth ME, Yancopoulos GD 1991 Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10:558-568
32. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD 1991 ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675
33. Han J, Lee JD, Bibbs L, Ulevitch RJ 1994 A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811
34. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler R, Saye JA, Smith RO 1993 Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205-251
35. Wolf G, Neilson EG 1993 Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540
36. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J 2001 Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10:321-329
37. Ruiz-Ortega M, Egido J 1997 Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 52:1497-1510
38. Robinson MJ, Cobb MH 1997 Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186
39. Omori S, Hida M, Ishikura K, Kuramochi S, Awazu M 2000 Expression of mitogen-activated protein kinase family in rat renal development. Kidney Int 58:27-37
40. Hida M, Omori S, Awazu M 2002 ERK and p38 MAP kinase are required for rat renal development. Kidney Int 61:1252-1262
41. di Mari JF, Davis R, Safirstein RL 1999 MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 277:F195-F203
42. Masaki T, Foti R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ 2003 Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int 63:1256-1264
43. Fogo A, Yoshida Y, Yared A, Ichikawa I 1990 Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 38:1068-1074